Talk:COVID-19 vaccine

This is the talk page for discussing improvements to the COVID-19 vaccine article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Archives: 1, 2, 3, 4, 5: 14 days

Template:COVID19 sanctions

WikiProject COVID-19 consensus

WikiProject COVID-19 aims to add to and build consensus for pages relating to COVID-19. They have so far discussed items listed below. Please discuss proposed improvements to them at the project talk page.

General

Superseded by TfD October 2020 and later practice - consult regular {{Current}} guidance.

Refrain from using Worldometer (worldometers.info) as a source due to common errors being observed as noted on the Case Count Task Force common errors page. (April 2020, April 2020)

For infoboxes on the main articles of countries, use Wuhan, Hubei, China for the origin parameter. (March 2020)

"Social distancing" is generally preferred over "physical distancing". (April 2020, May 2020)

Page title

COVID-19 (full caps) is preferable in the body of all articles, and in the title of all articles/category pages/etc.(RM April 2020, including the main article itself, RM March 2021).

SARS-CoV-2 (exact capitalisation and punctuation) is the common name of the virus and should be used for the main article's title, as well as in the body of all articles, and in the title of all other articles/category pages/etc. (June 2022, overturning April 2020)

Map

There is no consensus about which color schemes to use, but they should be consistent within articles as much as possible. There is agreement that there should be six levels of shading, plus gray for areas with no instances or no data. (May 2020)

There is no consensus about whether the legend, the date, and other elements should appear in the map image itself. (May 2020)

For map legends, ranges should use fixed round numbers (as opposed to updating dynamically). There is no consensus on what base population to use for per capita maps. (May 2020)

To ensure you are viewing the current list, you may wish to purge this page.

COVID-19 B‑class Top‑importance

	COVID-19 portal This article is within the scope of WikiProject COVID-19, a project to coordinate efforts to improve all COVID-19-related articles. If you would like to help, you are invited to join and to participate in project discussions.COVID-19Wikipedia:WikiProject COVID-19Template:WikiProject COVID-19COVID-19 articles
B	This article has been rated as B-class on Wikipedia's content assessment scale.
Top	This article has been rated as Top-importance on the project's importance scale.

Disaster management B‑class Top‑importance

	This article is within the scope of WikiProject Disaster management, a collaborative effort to improve the coverage of Disaster management on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Disaster managementWikipedia:WikiProject Disaster managementTemplate:WikiProject Disaster managementDisaster management articles
B	This article has been rated as B-class on Wikipedia's content assessment scale.
Top	This article has been rated as Top-importance on the project's importance scale.

Medicine: Emergency / Pulmonology B‑class High‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
B	This article has been rated as B-class on Wikipedia's content assessment scale.
High	This article has been rated as High-importance on the project's importance scale.
	This article is supported by the Emergency medicine and EMS task force (assessed as Top-importance).
	This article is supported by the Pulmonology task force (assessed as Mid-importance).
	An editor has requested that an image or photograph be added to this article.

Viruses B‑class Top‑importance

	Viruses portal This article is within the scope of WikiProject Viruses, a collaborative effort to improve the coverage of viruses on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.VirusesWikipedia:WikiProject VirusesTemplate:WikiProject Virusesvirus articles
B	This article has been rated as B-class on Wikipedia's content assessment scale.
Top	This article has been rated as Top-importance on the project's importance scale.
	An editor has requested that an image or photograph be added to this article.

Daily pageviews of this article

A graph should have been displayed here but graphs are temporarily disabled. Until they are enabled again, visit the interactive graph at pageviews.wmcloud.org

On 11 March 2020, it was proposed that this article be moved from COVID-19 vaccine to Coronavirus disease 2019 vaccine research. The result of the discussion was no consensus.

On 13 April 2020, it was proposed that this article be moved from COVID-19 vaccine to COVID-19 vaccine development. The result of the discussion was no consensus.

Template:Findnote

This is the talk page for discussing improvements to the COVID-19 vaccine article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Archives: 1, 2, 3, 4, 5: 14 days

RfC: emergency approval authorization

The UAE has approved Sinopharm's Covid-19 vaccine for frontline workers following successful Phase III clinical trials in Abu Dhabi. "The results of studies during the final stages of the Phase III trial showed that the vaccine is effective and resulted in a strong response, and the generation of antibodies to the virus. Studies on the safety of the vaccination have been reviewed and showed that it is safe and safe for use." said Minister of Health Abdulrahman Al Owais. The WHO-recognized trial began on July 16 and involved 31,000 volunteers. (The National).

This is significant in that a 3rd party government has approved of emergency use of COVID-19 vaccine following two months of Phase III trials. Its quite different from China and Russia's earlier approval of vaccine use which generated some skepticism since emergency approval was prior to Phase III testing and also the vaccine was developed by the respective countries, hence fears of "vaccine nationalism." I have included a small blurb in the vaccine table showing emergency approval in the UAE for healthcare workers. Am interested in hearing other proposals, as emergency approvals from other countries will also start coming hard and fast. Albertaont (talk) 20:59, 14 September 2020 (UTC)[reply]

Oppose. This is news and, imo, transient, unencyclopedic information - WP:NOTNEWS. There's no possibility of a "successful" Phase III trial result obtained in 2 months (months-years for a typical vaccine). "Interim" results are not final, but rather a glimpse of a trend in data, and the safety conclusion by the UAE minister is premature. In this case, the only safety data published are from the Phase I-II trials on less than 100 people per group - PMID 32789505. Governments are free to declare EUA for their own situation - which will generate news - but an encyclopedia should rely on evidence from published results to justify a decision to approve EUA or not. Zefr (talk) 23:09, 14 September 2020 (UTC)[reply]

New review

Should be useful:

Tregoning JS, Brown ES, Cheeseman HM, Flight KE, Higham SL, Lemm NM, Pierce BF, Stirling DC, Wang Z, Pollock KM (2020). "Vaccines for COVID‐19". Clinical & Experimental Immunology (Review). doi:10.1111/cei.13517. ISSN 0009-9104.

Alexbrn (talk) 07:41, 18 September 2020 (UTC)[reply]

Janssen phase III

The Janssen candidate (Ad26.COV2.S) has begun its 60,000-strong phase III trial. Should this be updated in the table?

https://www.jnj.com/johnson-johnson-initiates-pivotal-global-phase-3-clinical-trial-of-janssens-covid-19-vaccine-candidate

I Am Rufus • Conversation is a beautiful thing. 11:26, 23 September 2020 (UTC)[reply]

Estimated Release Date

I think the single most important question any reader has when seeking articles of the sort is "WHEN"!

- The table under COVID-19 vaccine#Vaccine candidates cannot be sorted accordingly. The last column of 'Duration' should split in two so that one can sort using end-dates for the phases, and dates should be written in the format yyyy-mm(-dd) so that this is feasible.

- Also certain vaccines have been approved for "Early or Limited Use" in certain countries (e.g. to medical staff, soldiers etc). This link by the New York Times has a great graphic with the number of vaccines in every phase right at the top and a whole section with details on this. There should be a greener color for those vaccines in the table and these details should be included (if the informed editors here think this or other sources of the sort are reliable).

- And finally there are some other early releases due to political (not necessarily 100% scientific) decisions which should be mentioned. A large number of politicians obviously think the economic consequences and/or the disease itself can lead to graver health problems than the possible side effects.

All of the above can help the reader understand better the possible answer to the "WHEN" question at a glance. Niko Silver 13:56, 15 October 2020 (UTC)[reply]